2021
DOI: 10.1007/978-1-0716-1286-6_18
|View full text |Cite
|
Sign up to set email alerts
|

Alteration of Flavin Cofactor Homeostasis in Human Neuromuscular Pathologies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 86 publications
0
9
0
Order By: Relevance
“…These also include intron variant, splice site, frameshift and synonymous [ 15 ]. Even dominantly acting SLC52A1 variants and gene deletions have recently been reported in clinical cases and have causally been linked to placental transport defects [ 15 , 16 ]. Specifically, SLC52A1 haploinsufficiency was identified in two asymptomatic women as the cause of biochemical abnormalities in their newborns resembling those of multiple acyl CoA dehydrogenase deficiency (MADD), a typical muscular lipid-storage disorder characterized by defects in the oxidation of fatty acids and amino acids leading to a clinically heterogeneous disease associated with metabolic acidosis, cardiomyopathy, liver disease, episodes of metabolic decompensation, weakness muscle, and respiratory failure [ 15 , 16 ].…”
Section: Riboflavin Transporter Deficiency: From Genetics To Clinical...mentioning
confidence: 99%
See 3 more Smart Citations
“…These also include intron variant, splice site, frameshift and synonymous [ 15 ]. Even dominantly acting SLC52A1 variants and gene deletions have recently been reported in clinical cases and have causally been linked to placental transport defects [ 15 , 16 ]. Specifically, SLC52A1 haploinsufficiency was identified in two asymptomatic women as the cause of biochemical abnormalities in their newborns resembling those of multiple acyl CoA dehydrogenase deficiency (MADD), a typical muscular lipid-storage disorder characterized by defects in the oxidation of fatty acids and amino acids leading to a clinically heterogeneous disease associated with metabolic acidosis, cardiomyopathy, liver disease, episodes of metabolic decompensation, weakness muscle, and respiratory failure [ 15 , 16 ].…”
Section: Riboflavin Transporter Deficiency: From Genetics To Clinical...mentioning
confidence: 99%
“…RFVTs are predicted to have 11 transmembrane domains [ 17 ]. However, it is possible that RFVTs might exist in different isoforms due to alternative processing of each transcript [ 16 ]. These proteins are responsible for transporting RF across cell membranes and are widely distributed in tissues throughout the body, with RFVT-2 and -3 being mostly expressed in the intestines, brain, and spinal cord [ 11 , 18 ] or produced by the intestinal microbiota, to a lesser extent.…”
Section: Riboflavin Transporter Deficiency: From Genetics To Clinical...mentioning
confidence: 99%
See 2 more Smart Citations
“…12,13 Mutations of FLAD1 gene severely affect muscular and cardiac functionality in humans. [11][12][13]15 Other genes correlated to Rf homeostasis are causative of metabolic neuromuscular disorders (for exhaustive reviews see References 12,16 and references therein). Noteworthy is the Brown-Vialetto-Van Laere Syndrome (BVVLS, also known as Rf Transporter Deficiency, RTD), a rare neurological disease in which the functionality of either SLC52A3 (BVVLS1, OMIM #211530) or SLC52A2 (BVVLS2, OMIM #614707) is altered.…”
Section: Introductionmentioning
confidence: 99%